MedTrace Logo

Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients

NCT05705219 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2026-01-26

No results posted yet for this study

Summary

This clinical trial studies how well 3-dimensional multi-parametric ultrasound (3D MPUS) imaging works as a decision-support tool for patients with liver tumors undergoing therapy. Continuous and dynamic imaging of patients undergoing therapy is required to monitor early-phase treatment response.

Conditions

  • Liver Cancer, Adult

Interventions

DIAGNOSTIC_TEST

3D-MPUS

Participants will receive approximately \< 20 minutes ultrasound scan to locate the lesion followed by acquisition of 3D-MPUS acquisition.

Sponsors & Collaborators

Principal Investigators

  • Ahmed El Kaffas, PhD · University of California, San Diego

  • Aya Kamaya, MD · Stanford University

  • Andrej Lyshchik, MD, PhD · Thomas Jefferson University

  • Aman Khurana, MD · University of California, San Diego

  • Yuko Kono, MD, PhD, FAIUM, FAASLD · University of California, San Diego

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-04
Primary Completion
2027-12-31
Completion
2028-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05705219 on ClinicalTrials.gov